FREQUENCY OF HUMAN CYP2D6 MUTANT ALLELES IN A NORMAL CHINESE POPULATION

被引：26

作者：

LEE, EJD ^{[1
]}

JEYASEELAN, K ^{[1
]}

机构：

[1] NATL UNIV SINGAPORE,DEPT BIOCHEM,SINGAPORE 0511,SINGAPORE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 37卷 / 06期

关键词：

GENETIC POLYMORPHISM; CYP2D6; CHINESE CYTOCHROME P450;

D O I：

10.1111/j.1365-2125.1994.tb04311.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Substantial differences in the pharmacogenetics of debrisoquine hydroxylation exist between Caucasians and Chinese populations. Among Chinese, not only is the frequency of the poor metabolizer phenotype low, the contribution of the 29B mutation in the CYP2D6 gene is insignificant. By contrast the frequency of D6-J is very common (similar to 0.6) and is clearly related to the activity of debrisoquine hydroxylase. Its presence however, does not predict the poor metabolizer phenotype. The D6-C mutation was also not detectable in our population.

引用

页码：605 / 607

页数：3

共 50 条

[1] Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population
Cai, W. M.
Chen, B.
Zhang, W. X.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 95 - 98
[2] Common mutant alleles of CYP2D6 causing the defect of CYP2D6 enzyme activity in a Japanese population
Ishiguro, A
Kubota, T
Sasaki, H
Yamada, Y
Iga, T
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 414 - U3
[3] Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes
Kubota, T
Yamaura, Y
Ohkawa, N
Hara, H
Chiba, K
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (01) : 31 - 34
[4] Nomenclature for human CYP2D6 alleles
Daly, AK
Brockmoller, J
Broly, F
Eichelbaum, M
Evans, WE
Gonzalez, FJ
Huang, JD
Idle, JR
IngelmanSundberg, M
Ishizaki, T
JacqzAigrain, E
Meyer, UA
Nebert, DW
Steen, VM
Wolf, CR
Zanger, UM
PHARMACOGENETICS, 1996, 6 (03): : 193 - 201
[5] Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population
Friedrich, Deise C.
Genro, Julia P.
Sortica, Vinicius A.
Suarez-Kurtz, Guilherme
de Moraes, Maria Elizabete
Pena, Sergio D. J.
Ribeiro dos Santos, Andrea K.
Romano-Silva, Marco A.
Hutz, Mara H.
PLOS ONE, 2014, 9 (10):
[6] Genetic variations of human CYP2D6 in the Chinese Han population
Qian, Jian-Chang
Xu, Xin-Min
Hu, Guo-Xin
Dai, Da-Peng
Xu, Ren-Ai
Hu, Li-Ming
Li, Fang-Hong
Zhang, Xiu-Hua
Yang, Jie-Fu
Cai, Jian-Ping
PHARMACOGENOMICS, 2013, 14 (14) : 1731 - 1743
[7] CYP2D6 polymorphism in a Gabonese population:: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype
Panserat, S
Sica, L
Gérard, N
Mathieu, H
Jacqz-Aigrain, E
Krishnamoorthy, R
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 121 - 124
[8] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
Shiran, Mohammad R.
Soteh, Mohammad B. Hashemi
Merat, Fatemeh
Sarzare, Fatemeh
Salehifar, Ebrahim
DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
[9] Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro
Su, Ying
Liang, Bing-qing
Feng, Yan-lin
Zhan, Yunyun
Gu, Ermin
Chen, Xinxin
Dai, Da-Peng
Hu, Guo-xin
Cai, Jian-ping
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (08) : 895 - 899
[10] Frequency of Five Important CYP2D6 Alleles Within an Iranian Population (Eastern Azerbaijan)
Kouhi, Hamed
Hamzeiy, Hossein
Barar, Jaleh
Asadi, Masoud
Omidi, Yadollah
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (05) : 665 - 670

← 1 2 3 4 5 →